Filing Details
- Accession Number:
- 0001127602-20-030334
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-02 17:34:32
- Reporting Period:
- 2020-11-30
- Accepted Time:
- 2020-12-02 17:34:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1110803 | Illumina Inc. | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1222644 | P Robert Ragusa | 5200 Illumina Way San Diego CA 92122 | Svp, Global Quality & Ops | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-11-30 | 180 | $311.34 | 6,802 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-30 | 926 | $312.35 | 5,876 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-30 | 50 | $313.13 | 5,826 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-30 | 580 | $314.74 | 5,246 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-30 | 150 | $315.76 | 5,096 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-30 | 834 | $317.44 | 4,262 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-30 | 120 | $318.83 | 4,142 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-30 | 50 | $319.50 | 4,092 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 180 shares sold ranging from $311 to $311.99 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 926 shares sold ranging from $312.01 to $312.85 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 580 shares sold ranging from $314.25 to $315.21 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 150 shares sold ranging from $315.28 to $316 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 834 shares sold ranging from $317.12 to $318.02 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 120 shares sold ranging from $318.39 to $319.37 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Billionaire Hedge Funds
